Ameriprise Financial Inc Biovie Inc. Transaction History

Ameriprise Financial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.69 - $16.93 $483,553 - $1.22 Million	-72,280 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$10.57 - $21.61 $196,559 - $401,859	-18,596 Reduced 20.46%	72,280 $1.23 Million
Q1 2021 May 17, 2021	BUY	$14.35 - $44.81 $1.3 Million - $4.07 Million	90,876 New	90,876 $1.76 Million

4.73M

17.2K

27K

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $83.6M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.